Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Market movers: GameStop, Okta, Abercrombie, Candel Therapeutics...

Salesforce Inc (NYSE:CRM, ETR:FOO) shares moved higher in after-hours trade as the customer relationship management platform’s first quarter fiscal 2026 financial results topped Wall Street estimates and it boosted its full-year revenue outlook.

The company reported earnings per share (EPS) of $2.58, higher than the consensus estimate of $2.54.

Read more

Joby Aviation Inc (NYSE:JOBY) shares surged almost 30% after it closed a $250 million investment from Toyota Motor Corporation.

The investment, the first tranche of a previously announced $500 million strategic investment, will support the certification and commercial production of Joby’s electric air taxi.

Read more

GameStop Corp (NYSE:GME) has jumped headfirst into crypto, revealing on Wednesday that it bought 4,710 Bitcoin — a stash worth roughly $513 million at current prices.

The video game retailer didn’t say when it made the purchase, what it paid, or whether the move happened all at once or in stages. But the investment comes just a couple of months after GameStop updated its corporate policy in March to allow for cryptocurrency holdings.

Read more

Abercrombie & Fitch (NYSE:ANF) shares popped after the clothing retailer posted record first quarter sales of $1.1 billion, led by growth in its Hollister brand.

First quarter sales were up 8% from the year-ago quarter, as Hollister sales jumped 22% to approximately $549 million.

Read more

Candel Therapeutics Inc (NASDAQ:CADL) said on Wednesday the US Food and Drug Administration has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its lead immunotherapy candidate, CAN-2409, for the treatment of newly diagnosed localized prostate cancer in patients with intermediate- to high-risk disease.

The RMAT designation is intended to expedite the development and review of regenerative therapies for serious conditions where preliminary evidence suggests the drug may address unmet medical needs.

Read more

Okta Inc (NASDAQ:OKTA) delivered first quarter financial results that beat Wall Street expectations, but shares traded more than 13% lower on Wednesday morning as it issued conservative guidance, citing macro uncertainty.

For the first quarter, the identity and access management firm reported revenue of $688 million, up 12% year-over-year and above consensus estimates of $680.3 million. Subscription revenue increased 12% to $673 million.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK